“Gastroparesis Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Gastroparesis Market.
The Gastroparesis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Gastroparesis Pipeline Report:
Companies across the globe are diligently working toward developing novel Gastroparesis treatment therapies with a considerable amount of success over the years.
Gastroparesis companies working in the treatment market are CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharmaceuticals, Takeda, Neurogastrx, Inc, PTC Therapeutics, Theravance Biopharma, Chugai Pharma, GlaxoSmithKline, Processa Pharmaceuticals, and others, are developing therapies for the Gastroparesis treatment
Emerging Gastroparesis therapies in the different phases of clinical trials are- CIN-102, Metoclopramide Nasal Spray, Tradipitant, IW-9179, TAK-954, NG101, CNSA-001, velusetrag, GM-611, Camicinal, PCS12852, and others are expected to have a significant impact on the Gastroparesis market in the coming years.
In September 2024, The US Food and Drug Administration (FDA) has rejected the new drug application (NDA) submitted by Vanda Pharmaceuticals for the use of tradipitant in treating gastroparesis symptoms.
Gastroparesis Overview
Gastroparesis is a condition that affects the stomach’s ability to empty its contents due to nerve damage caused by diabetes. The condition occurs when high blood sugar levels over time damage the vagus nerve, which controls the muscles of the stomach. This results in delayed gastric emptying, causing symptoms like nausea, vomiting, bloating, abdominal pain, and feeling full quickly after eating. It can lead to poor blood sugar control and malnutrition. Treatment focuses on managing blood sugar levels, dietary changes, and medications to improve stomach motility and relieve symptoms.
Get a Free Sample PDF Report to know more about Gastroparesis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/gastroparesis-pipeline-insight
Emerging Gastroparesis Drugs Under Different Phases of Clinical Development Include:
CIN-102: CinDome Pharma, Inc.
Metoclopramide Nasal Spray: Evoke Pharma
Tradipitant: Vanda Pharmaceuticals
IW-9179: Ironwood Pharmaceuticals
TAK-954: Takeda
NG101: Neurogastrx, Inc
CNSA-001: PTC Therapeutics
velusetrag: Theravance Biopharma
GM-611: Chugai Pharma
Camicinal: GlaxoSmithKline
PCS12852: Processa Pharmaceuticals
Gastroparesis Route of Administration
Gastroparesis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
Oral
Parenteral
Intravenous
Subcutaneous
Topical
Gastroparesis Molecule Type
Gastroparesis Products have been categorized under various Molecule types, such as
Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy
Gastroparesis Pipeline Therapeutics Assessment
Gastroparesis Assessment by Product Type
Gastroparesis By Stage and Product Type
Gastroparesis Assessment by Route of Administration
Gastroparesis By Stage and Route of Administration
Gastroparesis Assessment by Molecule Type
Gastroparesis by Stage and Molecule Type
DelveInsight’s Gastroparesis Report covers around 11+ products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration
Further Gastroparesis product details are provided in the report. Download the Gastroparesis pipeline report to learn more about the emerging Gastroparesis therapies
Some of the key companies in the Gastroparesis Therapeutics Market include:
Key companies developing therapies for Gastroparesis are – Bayer AG, Cipla Limited, Evoke Pharma, Pfizer Inc., Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Salix Pharmaceuticals, Inc., The Takeda Pharmaceutical, Teva Pharmaceutical, and others.
Gastroparesis Pipeline Analysis:
The Gastroparesis pipeline report provides insights into
The report provides detailed insights about companies that are developing therapies for the treatment of Gastroparesis with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Gastroparesis Treatment.
Gastroparesis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Gastroparesis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Gastroparesis market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Gastroparesis drugs and therapies
Gastroparesis Pipeline Market Drivers
Growing prevalence of diabetes, Unmet medical need, Advancements in drug development, Improved awareness and diagnosis, Regulatory support for innovation, are some of the important factors that are fueling the Gastroparesis Market.
Gastroparesis Pipeline Market Barriers
However, Limited effective treatment options, Challenges in drug development, Adverse side effects, High treatment costs, Regulatory challenges, and other factors are creating obstacles in the Gastroparesis Market growth.
Scope of Gastroparesis Pipeline Drug Insight
Coverage: Global
Key Gastroparesis Companies: CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharmaceuticals, Takeda, Neurogastrx, Inc, PTC Therapeutics, Theravance Biopharma, Chugai Pharma, GlaxoSmithKline, Processa Pharmaceuticals, and others
Key Gastroparesis Therapies: CIN-102, Metoclopramide Nasal Spray, Tradipitant, IW-9179, TAK-954, NG101, CNSA-001, velusetrag, GM-611, Camicinal, PCS12852, and others
Gastroparesis Therapeutic Assessment: Gastroparesis current marketed and Gastroparesis emerging therapies
Gastroparesis Market Dynamics: Gastroparesis market drivers and Gastroparesis market barriers
Request for Sample PDF Report for Gastroparesis Pipeline Assessment and clinical trials
Table of Contents
1. Gastroparesis Report Introduction
2. Gastroparesis Executive Summary
3. Gastroparesis Overview
4. Gastroparesis- Analytical Perspective In-depth Commercial Assessment
5. Gastroparesis Pipeline Therapeutics
6. Gastroparesis Late Stage Products (Phase II/III)
7. Gastroparesis Mid Stage Products (Phase II)
8. Gastroparesis Early Stage Products (Phase I)
9. Gastroparesis Preclinical Stage Products
10. Gastroparesis Therapeutics Assessment
11. Gastroparesis Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Gastroparesis Key Companies
14. Gastroparesis Key Products
15. Gastroparesis Unmet Needs
16 . Gastroparesis Market Drivers and Barriers
17. Gastroparesis Future Perspectives and Conclusion
18. Gastroparesis Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Gaurav BoraEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/
